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What is the impact of introducing inpatient electronic 
prescribing on prescribing errors?  A naturalistic stepped 
wedge study in an English teaching hospital 
 
Abstract 
Most studies evaluating the impact of electronic prescribing (eP) on prescribing safety 
have used comparatively weak study designs such as uncontrolled before-and-after 
studies. This study aimed to apply a more robust naturalistic stepped wedge study design 
to compare the prevalence and types of prescribing errors for eP and paper prescribing. 
Data were collected weekly during a phased eP implementation across 20 wards in a 
large English hospital.  We identified 511 (7.8%) erroneous orders in 6,523 paper 
medication orders, and 312 (6.0%) in 5,237 eP orders.  Logistic regression suggested no 
statistically significant effect of eP use or of study week; patient and ward had significant 
effects. Errors involving incorrect doses and illegible or incomplete orders were less 
common with eP; those involving duplication, omission, incorrect drug and incorrect 
formulation were more common. Actions are needed to mitigate these error types; future 
studies should give more consideration to the effects of patient and ward.  
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Background 
Medication errors are a global priority,1 with prescribing errors in the hospital setting a 
significant concern. An international systematic review reported a median prescribing 
error rate of 7% of medication orders, and 52 errors per 100 admissions.2 Studies in the 
United Kingdom (UK) have reported prescribing errors in 7.5-14.7% of inpatient 
medication orders.3-6 While not all such errors result in patient harm, all can create 
additional work and reduce patients’ confidence in their care.4 Many initiatives have been 
proposed in an attempt to reduce such errors; in particular, electronic prescribing (eP) 
systems, allowing ordering or prescribing of medication electronically with varying 
degrees of clinical decision support, have been widely advocated to improve prescribing 
safety.7 
 
Studies of the impact of eP on prescribing errors generally demonstrate significant 
reductions in medication errors.8-11 However, the majority of studies have used 
comparatively weak study designs, such as uncontrolled before-and-after studies, rather 
than more robust designs such a stepped wedge study12 where different clinical areas 
change from paper to eP at different times. There are few UK studies, with the majority 
of studies originating in the USA.13 Of the few UK studies published, most are in specific 
clinical areas.14-17 The English Government is committed to increasing use of eP in 
 2 
hospitals with its use expected to increase significantly in coming years.7,18-20 It is 
therefore important to understand the impact of introducing eP using a robust study 
design in the UK setting, where practices differ in some respects from those in the USA. 
In particular, UK hospitals do not mandate pharmacist verification of each medication 
order prior to any doses being administered, unit dose drug distribution is not used and 
there is greater use of ward stock and patients’ own medication supplies.   
 
Our aim was to evaluate the impact of introducing eP on prescribing errors in an English 
teaching hospital, using a stepped wedge study design. Objectives were to compare the 
following for paper-based prescribing and eP: 1) prescribing error rates, 2) types of 
prescribing errors, 3) the number of doses given (or omitted) before erroneous medication 
orders were corrected; and 4) to make recommendations as needed to improve 
prescribing safety in English hospitals in the context of eP. 
 
Methods 
Study design and setting 
 
We studied a 500-bed London teaching hospital introducing eP as part of a wider 
implementation of a commercially available electronic health record and electronic 
ordering system (Cerner Millennium). The hospital implemented eP during 2016 in all 20 
adult non-critical care inpatient areas during a phased roll-out according to the 
organisation’s eP implementation plan. We therefore used a naturalistic stepped-wedge 
study design21 based on the organisation’s implementation plan, rather than a cluster 
randomised stepped-wedge design in which the order in which clinical areas 
implemented eP would have been randomised.12  
 
At the start of the study, all inpatient prescribing was paper-based. Prescribers hand-
wrote medication orders on pre-formatted paper drug-charts. This involved writing the 
drug name, dose, route, frequency, time of administration and any additional instructions, 
and signing and dating each medication order. Following eP implementation, medication 
was ordered using the eP system by specifying these details using either drop-down 
menus or free text. Clinical decision support in operation at the time of the study 
comprised pre-programmed suggested dosing regimens (‘order sentences’) for commonly 
used drugs, lists of multiple orders typically required for particular situations (‘care sets’), 
patient-specific drug-allergy notifications, and reminder alerts to encourage timely review 
of medication such as anti-infectives. For anti-infective medications, prescribers were 
also required to state its indication and duration. Drug interaction checking and dose 
range alerts were not in operation at the time of data collection.  
 
Pharmacists provided a typical UK ward pharmacy service, with most wards visited by a 
pharmacist for 1-3 hours each weekday. Pharmacists checked inpatient medication orders 
to ensure they were clear, legal and clinically appropriate. Standard practice was that any 





Following briefings in team meetings and via email, ward pharmacists were asked to 
collect data once a week on all included wards for 16 weeks from 13 January to 28 April 
2016 inclusive. At the start of the data collection period, all prescribing was paper-based; 
data collection continued as wards went live with eP in five stages at weeks 6, 7, 10, 11 
and 12 (table 1).  
 
 Week 1 Week 6 Week 7 Week 10 Week 11 Week 12 
Number wards 
using paper 
20 18 14 10 6 0 
Number wards 
using eP 
0 2 6 10 14 20 
Table 1: Roll out of electronic prescribing (eP) by week 
 
 
Data were collected as part of pharmacists’ usual clinical duties; data were ideally 
collected on Wednesdays but we allowed some flexibility for pharmacists to collect data 
on the Tuesday or Thursday instead if necessary.  
 
A data collection form was developed based on previous work;4 this was given to 
pharmacists together with a written and verbal briefing.  Data were recorded for all new 
‘regular’ and ‘when required’ medication orders that had not already been screened by a 
pharmacist or discontinued. Drugs prescribed on supplementary paper drug charts, 
oxygen, ‘once only’ doses and continuous intravenous infusions were excluded to 
simplify data collection as these types of medication order are less common and/or not 
consistently screened by pharmacists. Recorded data comprised the bed number, number 
of previously unscreened medication orders and, for any errors identified, brief details of 
drugs involved and the error type.  As a measure of system resilience, we also asked 
pharmacists to record the number of doses given or omitted before the error was 
corrected.4 Each individual prescribing error was classified into one of thirteen mutually 
exclusive types;4 each medication order could be associated with more than one error. If a 
patient was an inpatient for at least two consecutive weeks, they could be included more 
than once. 
 
Sample size calculation  
 
Based on 20 wards being included and 40 new medication orders being screened each 
day on each ward, 4 we estimated that we would be able to include 800 medication orders 
at each of the 16 weekly time points. If the baseline prescribing error rate was 10%,4 we 
anticipated identifying 100 prescribing errors at each time point. Based on a simple two 
group comparison with 6,400 orders on each of paper and eP, this was calculated to be a 
sufficient sample to identify a reduction to 8.5% as being statistically significant using 
the 95% confidence interval (CI) for the difference between two proportions using alpha 





A medication order was defined as one drug prescribed for an inpatient; there are usually 
multiple medication orders on each patient’s inpatient drug chart or electronic 
prescription.4  
 
The definition of a prescribing error was “A prescribing error occurs when, as a result of 
a prescribing decision or prescription writing process, there is an unintentional, 
significant: reduction in the probability of treatment being timely and effective or 
increase in the risk of harm when compared to generally accepted practice”.23 This 





Data were entered into an Excel database. Errors that did not meet the study definition of 
an error were removed; pharmacists’ classifications of error types were checked by the 
authors and recoded where necessary to ensure consistency of classification.  
 
Univariate analysis was first conducted without taking into account clustering by patient 
or ward, and without controlling for time. The denominator for calculating the error rate 
was the number of newly written regular and ‘when required’ medication orders screened 
by ward pharmacists, plus any medication orders omitted.4,24 Ninety-five percent CI were 
presented for prescribing error rates with non-overlapping CIs taken to indicate statistical 
significance.25  
 
We then fitted a multivariable three-level fixed effects generalized linear model (logistic) 
using STATA IC version 15. The dependent variable was whether or not each medication 
order was erroneous; independent variables were ‘paper versus eP’ (categorical) and 
‘study week’ (linear). The three levels of hierarchy were to account for clustering of 
medication orders within patients, and clustering of patients within wards. Covariates 
were removed from the model if the likelihood ratio test of the hierarchical model was 
not significant (p>0.05). Random intercept logistic regression analysis confirmed there to 
be no significant effect of study week (p=0.153) together with a non-significant 
likelihood ratio test. The fixed-effect variable ‘study week’ was therefore removed from 
the model. The final model contained only ‘paper versus eP’ as a fixed effect variable. 
 





The study was approved locally as a service evaluation; ethics approval was not required.  
No patient or prescriber identifiers were recorded. Pharmacists’ names were recorded to 
permit follow up of any queries on data collection forms and then replaced with codes 




Pre- and post-eP data were collected for 20 wards in total, by 39 different pharmacists. 
Overall, 241 data collection forms were completed of a possible of 320 (75%). Return 
rates by week ranged from 55% (week 11) to 95% (weeks 2 and 4).  
 
Prevalence of prescribing errors  
 
A total of 11,586 newly written medication orders were reviewed by ward pharmacists 
during the study, of which 9,184 (79.3%) were for regular medication and 2,402 (20.7%) 
‘when required’. There were 174 prescribing omissions also identified, giving a total 
denominator of 11,760 for calculating the error rate. Of the 11,760 medication orders 
prescribed or omitted, 6,523 (55.4%) were on paper and 5,237 (44.5%) on eP. These 
relate to pharmacists reviewing charts for 4,036 patients during the study period.  There 
were 831 individual prescribing errors recorded in 823 (7.0%) of 11,760 medication 
orders, concerning 563 (13.9%) of 4036 patients.   
 
Of the 6,523 medication orders written on paper, 511 were erroneous, giving an error rate 
of 7.8% (95% CI 7.1% to 8.5%); most erroneous orders had one error except for eight 
which had two errors. Of the 5,237 eP orders, 312 were erroneous, giving an error rate of 
6.0% (95% CI 5.4% to 6.7%); all erroneous eP orders had only one error. The non-
overlapping CIs suggest a significant difference, with a lower error rate for eP.  Figure 1 
presents prescribing error rates by weeks post-implementation on the ward concerned, 





Figure 1: Prescribing error rates for electronic medication orders presented by weeks 
since electronic prescribing went live on the ward concerned. CI: confidence interval. 
 
 
The final three-level random intercept model suggested no statistically significant effect 
of eP use once clustering by patient and ward was taken into account (odds ratio 0.938 eP 
versus paper; 95% CI 0.727 to 1.210; p=0.621). Ward and patient (clustered within ward) 
both had significant effects (table 2).   
 
 
Variable Odds ratio for effect on erroneous 
medication orders (95% confidence 
interval) 
Electronic prescribing (with paper-
based prescribing as base category) 
0.938 (0.727 to 1.210) 
Ward variance 0.366 (0.172 to 0.775) 
Patient (within ward) variance 2.166 (1.690 to 2.775) 
Table 2: Results of three level random intercept logistic regression analysis 
 
 
A post-hoc descriptive analysis of error rates by ward is presented in figure 2, confirming 
that both error rates and the effect of eP varied by ward. The most dramatic error 
reductions associated with eP occurred on wards 1, 6, 10 and 19 which were day surgery, 
medical admissions, orthopaedics, and neurology. The most dramatic increases occurred 
on wards 11, 14 and 15 which were gastroenterology, medicine for the elderly, and acute 
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Lower 95% CI
Error rate per week since go
live
Upper 95% CI
Linear (Error rate per week
since go live)
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ward, and 0.435 (95% CI 0.376 to 0.496) for patient (within ward), suggesting that the 








Types of prescribing errors 
 
A breakdown of the different error types for paper and eP is given in figure 3, suggesting 
increases in duplication of the same drug, omission, incorrect drug and incorrect 
formulation with eP, and decreases in errors involving drugs that were not indicated or 
contraindicated, incorrect doses, illegible and incomplete orders with eP. Prevalence of 
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Rectification of errors 
 
Pharmacists recorded the number of doses given or omitted before the error was 
corrected for 624 of 823 (75.8%) erroneous medication orders. These data suggest that 
erroneous doses were more likely to be rectified in a timely fashion for paper-based 
prescribing (table 3).  
 
 Number of erroneous 
orders for which these 
data recorded (%) 
Mean number of 
doses given or 
omitted before error 
corrected (range) 
Number of orders in which 
error corrected before any 




389 of 513 (75.8%) 1.2 (0-8) 158 (40.6%) 
Electronic 
prescribing 
235 of 310 (75.8%) 1.8 (0-26) 102 (43.4%) 
Table 3: Summary of findings in relation to numbers of doses given (or omitted) before 









Overall, errors were identified in 7.7% of paper medication orders and 6.0% with eP. 
While univariate analysis suggests that this indicates a decrease with eP, multivariable 
analysis taking into account clustering by patient and ward suggests no statistically 
significant difference. Instead, the effects of ward and patient (within ward) were 
significant, suggesting that factors other than type of prescribing system have a 
significant impact on prescribing safety and the effect of eP. Our findings also confirm 
that certain types of errors are more likely with eP with others less likely.  
 
Interpretation and comparison with existing literature 
 
Previous studies of the effect of eP on prescribing errors generally suggest a reduction in 
prescribing errors. However such studies have not taken into account the effect of ward 
or patient, precluding comparison with our findings in this respect. A recent study of 
medication administration errors26 suggests clustering by ward to be an important factor; 
our study suggests that ward may also be important for prescribing errors.   
 
In line with previous studies, our findings indicate that eP changes the types of 
prescribing errors that occur.17 Perhaps unsurprisingly, there was a reduction in illegible 
and incomplete medication orders. Prescribing errors associated with the wrong dose also 
decreased, which is likely to be associated with the use of order sentences and order sets 
that are pre-populated with commonly used dosing regimens. However other error types 
increased. As in our study, previous research suggests an increase in errors associated 
with duplication of medication and the failure to discontinue drugs that are no longer 
needed.27-29 New errors have also been attributed to factors associated with the eP system 
itself and its usability, such as mis-selection from drop-down menus, inability to view all 
medication concomitantly, and failure to change default settings.29-31 
 
A previous study in the context of paper prescribing suggested that 0.9 doses were 
administered (or omitted) prior to errors being corrected,4 which compares to our figure 
of 1.2 for paper prescribing. However we also identified a higher figure of 2.0 with eP; it 
is not clear why errors were corrected less swiftly with eP.  
 
Strengths and limitations 
 
The main strength of this study was the application of a stepped wedge study design, 
which is considered more robust in comparison to uncontrolled before-and-after studies. 
In contrast to previous work in this area, we also took into account clustering by ward 
and patient. While slightly smaller than anticipated, we still achieved a large sample size 
of more than 11,000 medication orders.  
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Limitations include the return rate for pharmacists’ data collection forms, which ranged 
from 55% to 95%; weeks where the response rate was particularly low coincided with the 
introduction of eP on the ward concerned, suggesting that this affected data collection. 
Informal feedback suggested that failure to return data collection forms was due to 
forgetting to complete the forms or being too busy to record the data. The quality, 
accuracy and completeness of data collected may also vary depending on individual 
pharmacists. For example, data regarding the number of doses or given or omitted before 
errors were rectified was recorded for only 76% of errors. It was not possible to take into 
account any effect of prescriber since we did not record the prescriber for medication 
orders written or for errors identified, and although we had data on the pharmacist 
identifying each error, we were unable to take this into account in the model due to the 
large numbers of different pharmacists who collected data (n=39) and considerable 
correlation of pharmacist with ward. Finally, we did not assess the likely clinical 
significance of errors as pharmacists were asked for only very brief error descriptions to 
facilitate data collection, with no details of patients’ clinical conditions.  
 
Implications for practice and policy 
 
Our findings suggest that one of the purported benefits of introducing eP, namely a 
reduction in prescribing errors, may not be realised in practice. Instead we found a more 
nuanced effect with different effects on different wards, as well as different types of 
error. While other benefits in terms of legibility, clear audit trails and reduced reliance on 
paper storage mean that eP is likely to become ubiquitous, organisations introducing eP 
should take action to identify those error types that increase with eP and how they can be 
prevented. Based on our data, duplication of therapy is a key area on which to focus; a 
parallel qualitative study suggests that screen design is an important consideration in this 
respect with eP screens often precluding viewing of all prescribed medication at one 
time.31 Other eP-related factors that may influence prescribing errors include usability 
and system training.30-31 We recommend that organisations supplement implementation 
advice in published tools32,33 with local data on specific risks.  
 
Implications for research  
 
Our findings suggest ward to be a significant predictor of both prescribing error rates and 
the effect of eP. Subsequent research in this field should therefore take this into account 
in study design and analysis, as others have suggested elsewhere.34 It is not clear why eP 
increased the error rate on some wards, decreased it on others and had no apparent effect 
on others. While possible reasons include the effect of different prescribers and different 
pharmacists and/or wider cultural issues around medication safety, our data suggests that 
patient factors may be a significant contributor to this variation. It is not clear whether 
this is due to differences in clinical conditions, medications, or prescribers. Further 
research, both qualitative and quantitative, should therefore explore these areas, taking 
into account the sociotechnical context as well as other factors that can affect prescribing 
errors in the context of eP.30 Recent research also suggests that local implementation 
factors affect outcomes relating to safety and efficiency, even where the same 
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commercial system is implemented.35 Given that our findings suggest that errors were 
corrected less swiftly with eP, this is also an area for further investigation. 
 
Conclusion 
Our analysis suggests that eP has no statistically significant effect on the rate of 
erroneous medication orders, but that ward and patient have significant effects. Errors 
involving incorrect doses and illegible or incomplete orders were less common with eP; 
those involving duplication, omission, incorrect drug and incorrect formulation were 
more common. Actions are needed to mitigate these error types; future studies should 
give more consideration to the effect of ward and patient factors on prescribing error rates 
and the effect of eP.  
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